TB Alliance Drug Discovery and Development: Harnessing Global Resources to Address a Global Disease

by Thanos Panagiotidis | Apr 15, 2016 | Drug Discovery Applications, Publications and presentations

TB Alliance Drug Discovery and Development: Harnessing Global Resources to Address a Global Disease Dr Chris Cooper, TB Alliance, gave this presentation at “Streamlining Drug Discovery and Development” held in San Francisco, CA, USA on 14 April 2016....

Structure Guided Design and Optimization of Selective Kinase Inhibitors from Fragment Starting Points

by Thanos Panagiotidis | Apr 15, 2016 | Drug Discovery Applications, Publications and presentations

Structure Guided Design and Optimization of Selective Kinase Inhibitors from Fragment Starting Points Dr Steve Woodhead, Takeda, gave this presentation at “Streamlining Drug Discovery and Development” held in San Francisco, CA, USA on 14 April 2016....

Cheminformatics from the end-user perspective: Past, present and future

by Thanos Panagiotidis | Apr 15, 2016 | Drug Discovery Applications, Publications and presentations

Cheminformatics from the end-user perspective: Past, present and future Dr Paul Greenspan, Takeda, gave this presentation at “Streamlining Drug Discovery and Development” held in Cambridge, MA, USA on 11 April 2016. AbstractOver the course of my 25 year...

Speeding up and improving the Identification of a potent B2 agonist as a growth promoter for cattle

by Thanos Panagiotidis | Apr 15, 2016 | Drug Discovery Applications, Publications and presentations

Speeding up and improving the Identification of a potent B2 agonist as a growth promoter for cattle Dr Ashley Fenwick, Zoetis, gave this presentation at “Streamlining Drug Discovery and Development” held in Cambridge, MA, USA on 11 April 2016....

User-friendly Database Querying for Decision-Making in Drug Discovery

by Thanos Panagiotidis | Apr 15, 2016 | General, Publications and presentations

User-friendly Database Querying for Decision-Making in Drug Discovery This poster was presented by Chris Leeding, Ed Champness, Chris Mills*, Andrew Lemon*, Ashley Fenwick$ and Matt Segall at BioIT World Expo and Meeting in April 2016. * – The Edge Software...
« Older Entries

Recent Posts

  • Optibrium appoints Steve Yemm as Chief Commercial Officer
  • Introduction to StarDrop™
  • Real world case studies: Predicting pharmacokinetics from limited ADME data with deep learning
  • Inspyra™– Introduction
  • Cerella™– Introduction

Archives

Categories

  • Asteris
  • Cerella
  • Downloads
  • Drug Discovery Applications
  • Events
  • Example Code
  • General
  • In Silico Modelling
  • Latest Videos
  • Models
  • Multi-Parameter Optimisation
  • News
  • Ocura
  • Pipeline Pilot Protocols
  • Presentations and Webinars
  • Publications and presentations
  • Scoring Profiles
  • Scripts/Addons
  • StarDrop Hints and Tips
  • StarDrop Modules and Features
  • StarDrop Tutorials
  • Tutorials
  • Upcoming webinar
  • Videos
  • Webinars

Meta

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.

enquiries & support

General: [email protected]
StarDrop: [email protected]
Cerella: [email protected]
Press: [email protected]
Vacancies: [email protected]

  • Follow
  • Follow
further information

View our Privacy Policy

Copyright © 2023 Optibrium, Ltd. All Rights Reserved.
Optibrium™, StarDrop™, Augmented Chemistry®, Cerella™, Asteris™, Ocura™, Glowing Molecule™, WhichP450™, Auto-Modeller™, Nova™, MPO Explorer™ and Card View® are trademarks of Optibrium Ltd. Augmented Chemistry® is registered only in the UK and EU. Card View® is registered only in the United States. Matsy™ is a trademark of NextMove Software Ltd., BIOSTER™ is a trademark of iKem Szolgáltató és Kereskedelmi BT, Derek Nexus™ is a trademark of Lhasa Ltd., Surflex eSim3D is a trademark of BioPharmics LLC, and SeeSAR™ is a trademark of BioSolveIT GmbH. US Patent Numbers 9,224,098 and 9,367,812

Website designed and developed by Identity Creative.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}